Skip to main content
. 2021 Jan 26;22(3):1185. doi: 10.3390/ijms22031185
ACPAs anti-citrullinated peptide antibodies
AD Alzheimer’s disease
BBB blood–brain barrier
BDI Beck Depression Inventory
bDMARDs biological DMARDs
BDNF brain-derived neurotrophic factor
BVRT Benton Visual Retention Test
csDMARDs conventional synthetic DMARDs
CSF cerebrospinal fluid
DAS-28 Disease Activity Score
DHEADHEA-S dehydroepiandrosterone dehydroepiandrosterone sulfate
EULAR European League Against Rheumatism
fMRI functional MRI
GDNF glial-cell-line-derived neurotrophic factor
GFAP glial fibrillary acidic protein
MBP myelin basic protein
MCI mild cognitive impairment
MHC major histocompatibility complex
MMSE Mini-Mental State Examination
MoCA Montreal Cognitive Assessment
MOG myelin oligodendrocyte glycoprotein
MRI magnetic resonance imaging
NKT natural killer T cell
NO nitric oxide
NSAIDs non-steroidal anti-inflammatory drugs
PBMCs peripheral blood mononuclear cells
poly I:C polyinosinic:polycytidilic acid
RA rheumatoid arthritis
RF rheumatoid factor
S100β S100 calcium-binding β
Sal salidroside
SHH sonic hedgehog
SLE systemic lupus erythematosus
STAIT/S
TNF
State-Trait Anxiety Inventory
Tumor necrosis factor
TMT Trail-Making Test
TrkB tropomyosin-related kinase B
tsDMARDs targeted synthetic DMARDs
TTR serum paraoxonase
VST Victoria Stroop Test
WAIS Wechsler Adult Intelligence Scale